review article | Q7318358 |
scholarly article | Q13442814 |
meta-analysis | Q815382 |
P50 | author | James Januzzi | Q63144011 |
Rob Doughty | Q88239527 | ||
Roxy Senior | Q91296565 | ||
Mark Richards | Q105243769 | ||
Jens T Rosenberg | Q108645281 | ||
P2093 | author name string | Finn Gustafsson | |
Paul O Collinson | |||
Per Hildebrandt | |||
David C Gaze | |||
Ahmet Fuat | |||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
Meta-analysis in clinical trials | Q27860779 | ||
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 | ||
The effects of medications on circulating levels of cardiac natriuretic peptides | Q28212913 | ||
The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction | Q34351391 | ||
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. | Q35581313 | ||
Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial | Q35594969 | ||
Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure | Q35603212 | ||
Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients | Q37075374 | ||
Amino-terminal pro-B-type natriuretic peptide testing in renal disease | Q37075417 | ||
Understanding amino-terminal pro-B-type natriuretic peptide in obesity | Q37075421 | ||
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction | Q37108057 | ||
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology | Q40224176 | ||
N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis | Q40528931 | ||
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. | Q44220082 | ||
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial | Q45069603 | ||
Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers | Q45180221 | ||
N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea | Q47973118 | ||
Brain natriuretic peptide is elevated in outpatients with atrial fibrillation | Q48160360 | ||
Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure | Q48495727 | ||
Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations | Q48591524 | ||
The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective | Q48593408 | ||
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements | Q48805576 | ||
Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure | Q48860105 | ||
The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study | Q48881656 | ||
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? | Q53617945 | ||
P433 | issue | 15 | |
P921 | main subject | systole | Q496359 |
P304 | page(s) | 1881-1889 | |
P577 | publication date | 2010-06-02 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care | |
P478 | volume | 31 |
Q36449881 | Biochemical markers of aging for longitudinal studies in humans |
Q44566168 | Brain natriuretic peptide-guided management of chronic heart failure: first do no harm |
Q95660687 | Cardiac natriuretic peptides |
Q37691417 | Cardiovascular biomarkers and their utility in the older adult |
Q36267492 | Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood |
Q37356354 | Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study |
Q38518602 | Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer. |
Q55346961 | Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides? |
Q92925812 | Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations |
Q38148978 | Heart failure in very old adults |
Q37107428 | High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies. |
Q35058920 | Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension |
Q40715674 | Impact of using different guideline recommended serum natriuretic peptide thresholds on the diagnosis and referral rates of a diagnostic heart failure clinic. |
Q41548532 | Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old. |
Q49022172 | Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? |
Q45247270 | Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors |
Q46948868 | Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study |
Q35244261 | NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy |
Q34306307 | NT-ProBNP independently predicts long-term mortality in patients admitted for coronary angiography |
Q42230262 | NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome |
Q64233573 | Natriuretic Peptides in Chronic Heart Failure |
Q34614873 | Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials |
Q27027081 | Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure |
Q38223600 | Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review |
Q47687008 | Point-of-care testing in primary care patients with acute cardiopulmonary symptoms: a systematic review |
Q34492442 | Prevalence and treatment of heart failure in Swedish nursing homes |
Q40165610 | Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction |
Q41140893 | Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study |
Q61307046 | Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care |
Q41875333 | Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure. |
Q34304083 | Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study. |
Search more.